Sucralfate
21 NDCs across 15 manufacturers|19 Generic,2 Brand
Sucralfate is used to treat duodenal ulcer, esophagitis, gastritis, pneumonia, stomach ulcer and stomatitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Mar 29, 1996. FDA's Orange Book lists 14 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $130 million on Sucralfate across 2.4 million claims for 851,000 beneficiaries.
Sucralfate is available as 21 NDCs from 15 manufacturers (19 generic, 2 brand), with NADAC prices from $0.17 to $4.73 per EA — the most expensive product costs about 27× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
21
19G / 2B
Manufacturers
15
competing in market
Price Spread
$0.17 – $4.73
per EA, 13 of 21 NDCs
7d Activity
avg +1.0% WoW · of 21 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Aluminum Complex class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
15 manufacturers producing SUCRALFATE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CARAFATE 1 GM TABLET | $4.7308 per EA | -0.05% |
CARAFATE 1 GM/10 ML SUSP | $0.6104 per ML | — |
SUCRALFATE 1 GM TABLET | $0.1787 per EA | — |
SUCRALFATE 1 GM TABLET | $0.1727 per EA | +0.13% |
SUCRALFATE 1 GM TABLET | $0.1727 per EA | +0.13% |
SUCRALFATE 1 GM TABLET | $0.1727 per EA | +0.13% |
SUCRALFATE 1 GM TABLET | $0.1727 per EA | +0.13% |
SUCRALFATE 1 GM TABLET | $0.1727 per EA | +0.13% |
SUCRALFATE 1 GM TABLET | $0.1727 per EA | +0.13% |
SUCRALFATE 1 GM TABLET | $0.1727 per EA | +0.13% |
SUCRALFATE 1 GM TABLET | $0.1727 per EA | +0.13% |
SUCRALFATE 1 GM TABLET | $0.1727 per EA | +0.13% |
SUCRALFATE 1 GM TABLET | $0.1727 per EA | +0.13% |
SUCRALFATE 1 GM TABLET | $0.1727 per EA | +0.13% |
SUCRALFATE 1 GM/10 ML SUSP | $0.1241 per ML | +2.70% |
SUCRALFATE 1 GM/10 ML SUSP | $0.1241 per ML | +2.70% |
SUCRALFATE 1 GM/10 ML SUSP | $0.1241 per ML | +2.70% |
SUCRALFATE 1 GM/10 ML SUSP | $0.1241 per ML | +2.70% |
SUCRALFATE 1 GM/10 ML SUSP | $0.1241 per ML | +2.70% |
SUCRALFATE 1 GM/10 ML SUSP | $0.1163 per ML | +3.04% |
SUCRALFATE 1 GM/10 ML SUSP | $0.1153 per ML | — |
Frequently Asked Questions
What is Sucralfate used to treat?
Sucralfate is used to treat duodenal ulcer, esophagitis, gastritis, pneumonia, stomach ulcer and stomatitis, per the National Library of Medicine's MED-RT classification.
When did Sucralfate become available as a generic?
FDA approved the first generic Sucralfate (ANDA) on Mar 29, 1996. The Orange Book currently lists 14 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Sucralfate?
In 2024, Medicare Part D spent $130 million on Sucralfate across 2.4 million claims for 851,000 beneficiaries.
How many Sucralfate products are on the market?
The Sucralfate drug market contains 21 NDCs from 15 manufacturers — 19 generic and 2 brand products.
What is the price range for Sucralfate?
NADAC reference prices for Sucralfate range from $0.1727 to $4.7308 per EA — the most expensive product costs about 27× the cheapest. 8 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Sucralfate cheaper than brand?
The average generic NADAC for Sucralfate is $0.1732 per EA, versus $4.7308 for brand-labeled products — brand versions average about 27× the generic price.
Which manufacturers make Sucralfate?
15 manufacturers list Sucralfate in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (3), Allergan, Inc. (2), Amneal Pharmaceuticals NY LLC (2), Greenstone LLC (2), Viona Pharmaceuticals Inc. (2).
How has the price of Sucralfate changed recently?
Over the past 7 days, 17 Sucralfate NDCs rose and 1 fell, with a market-wide average change of +1.0%.